Annual Accounts Receivable
$6.57 M
+$3.47 M+111.66%
December 31, 2021
Summary
- As of February 10, 2025, EPZM annual accounts receivable is $6.57 million, with the most recent change of +$3.47 million (+111.66%) on December 31, 2021.
- During the last 3 years, EPZM annual accounts receivable has fallen by -$13.49 million (-67.25%).
Performance
EPZM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$11.21 M
+$5.31 M+89.94%
June 30, 2022
Summary
- As of February 10, 2025, EPZM quarterly accounts receivable is $11.21 million, with the most recent change of +$5.31 million (+89.94%) on June 30, 2022.
- Over the past year, EPZM quarterly accounts receivable has increased by +$4.09 million (+57.47%).
Performance
EPZM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
EPZM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.7% | +57.5% |
| 3 y3 years | -67.3% | -15.5% |
| 5 y5 years | +1620.4% | +10000.0% |
EPZM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -47.4% |
| 5 y | 5-year | at high | -60.9% | at high | -85.3% |
| alltime | all time | -80.5% | -99.7% | -66.7% | -99.9% |
Epizyme Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $11.21 M(+89.9%) |
| Mar 2022 | - | $5.90 M(-10.2%) |
| Dec 2021 | $6.57 M(+111.7%) | $6.57 M(+97.2%) |
| Sep 2021 | - | $3.33 M(-53.2%) |
| Jun 2021 | - | $7.12 M(-27.1%) |
| Mar 2021 | - | $9.76 M(+214.5%) |
| Dec 2020 | $3.10 M(+21.0%) | $3.10 M(-32.7%) |
| Sep 2020 | - | $4.61 M(+163.9%) |
| Jun 2020 | - | $1.75 M(+5.9%) |
| Mar 2020 | - | $1.65 M(-35.8%) |
| Dec 2019 | $2.57 M(-87.2%) | $2.57 M(-78.6%) |
| Sep 2019 | - | $12.00 M(-9.6%) |
| Jun 2019 | - | $13.27 M(+2.3%) |
| Mar 2019 | - | $12.98 M(-35.3%) |
| Dec 2018 | $20.07 M(+5153.1%) | $20.07 M(+62.6%) |
| Sep 2018 | - | $12.34 M(>+9900.0%) |
| Mar 2018 | - | $24.00 K(-93.7%) |
| Dec 2017 | $382.00 K | $382.00 K(+1428.0%) |
| Sep 2017 | - | $25.00 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $25.00 K(+212.5%) |
| Mar 2017 | - | $8000.00(-65.2%) |
| Dec 2016 | $23.00 K(-91.2%) | $23.00 K(-99.6%) |
| Sep 2016 | - | $6.20 M(>+9900.0%) |
| Jun 2016 | - | $60.00 K(-65.9%) |
| Mar 2016 | - | $176.00 K(-32.8%) |
| Dec 2015 | $262.00 K(-87.4%) | $262.00 K(+48.0%) |
| Sep 2015 | - | $177.00 K(-75.5%) |
| Jun 2015 | - | $723.00 K(+98.1%) |
| Mar 2015 | - | $365.00 K(-82.4%) |
| Dec 2014 | $2.08 M(-93.8%) | $2.08 M(-1.6%) |
| Sep 2014 | - | $2.11 M(-3.7%) |
| Jun 2014 | - | $2.19 M(-73.1%) |
| Mar 2014 | - | $8.15 M(-75.8%) |
| Dec 2013 | $33.67 M(+1740.7%) | $33.67 M(+1462.3%) |
| Sep 2013 | - | $2.15 M(-72.4%) |
| Jun 2013 | - | $7.81 M(+310.5%) |
| Mar 2013 | - | $1.90 M(+4.0%) |
| Dec 2012 | $1.83 M(-2.3%) | $1.83 M |
| Dec 2011 | $1.87 M | - |
FAQ
- What is Epizyme annual accounts receivable?
- What is the all time high annual accounts receivable for Epizyme?
- What is Epizyme annual accounts receivable year-on-year change?
- What is Epizyme quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Epizyme?
- What is Epizyme quarterly accounts receivable year-on-year change?
What is Epizyme annual accounts receivable?
The current annual accounts receivable of EPZM is $6.57 M
What is the all time high annual accounts receivable for Epizyme?
Epizyme all-time high annual accounts receivable is $33.67 M
What is Epizyme annual accounts receivable year-on-year change?
Over the past year, EPZM annual accounts receivable has changed by +$3.47 M (+111.66%)
What is Epizyme quarterly accounts receivable?
The current quarterly accounts receivable of EPZM is $11.21 M
What is the all time high quarterly accounts receivable for Epizyme?
Epizyme all-time high quarterly accounts receivable is $33.67 M
What is Epizyme quarterly accounts receivable year-on-year change?
Over the past year, EPZM quarterly accounts receivable has changed by +$4.09 M (+57.47%)